助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   transdermal fentanyl 的翻译结果: 查询用时:0.012秒
图标索引 在分类学科中查询
所有学科
肿瘤学
临床医学
外科学
感染性疾病及传染病
皮肤病与性病
心血管系统疾病
更多类别查询

图标索引 历史查询
 

transdermal fentanyl
相关语句
  芬太尼透皮贴剂
     Clinical Application of Transdermal Fentanyl (Durogesic) for 67 Patients with Cancer Pain
     芬太尼透皮贴剂(多瑞吉)治疗癌痛临床应用67例观察
短句来源
     86.2% patients preferred to receive transdermal fentanyl.
     86 2 %病人选择继续用芬太尼透皮贴剂
短句来源
     86.2% patients preferred continue treated by transdermal fentanyl.
     86.2%病人选择继续用芬太尼透皮贴剂
短句来源
     Objective To evaluate the efficacy and safety of Transdermal Fentanyl in the treatment of opioid naIve and morphine pretreated cancer patients.
     目的评价未接受过阿片类药物与使用过吗啡治疗的肿瘤患者使用芬太尼透皮贴剂治疗癌痛的疗效和安全性。
短句来源
     Group 1: transdermal Fentanyl 25ug/h for every 72 hours.
     组Ⅰ使用芬太尼透皮贴剂25μg/h,每72h一次。
短句来源
更多       
  透皮芬太尼
     A clinical study on the transdermal fentanyl used for postoperative pain relief
     透皮芬太尼贴剂用于术后镇痛的临床研究
短句来源
     The clinical use of transdermal fentanyl in the treatment of cancer pain
     透皮芬太尼在癌痛治疗中的应用
短句来源
     This report introduces the advantage of transdermal fentanyl and the ex perience about its use in cancer pain, which provides the theoretical basis for the clinical rational use of TTS fentanyl.
     本文综述了透皮芬太尼临床应用的优点及其在癌痛治疗的研究现状,从而为透皮芬太尼的临床应用提供了理论基础.
短句来源
  芬太尼透
     Clinical Application of Transdermal Fentanyl (Durogesic) for 67 Patients with Cancer Pain
     芬太尼透皮贴剂(多瑞吉)治疗癌痛临床应用67例观察
短句来源
     86.2% patients preferred to receive transdermal fentanyl.
     86 2 %病人选择继续用芬太尼透皮贴剂。
短句来源
     86.2% patients preferred continue treated by transdermal fentanyl.
     86.2%病人选择继续用芬太尼透皮贴剂。
短句来源
     METHODS:30patients with pate squamous carcinoma and serious membrana mucosa ulcerate and pain after a whole range radiotherapy,who were treated with3to5patches2.5mg(25μg/h)of transdermal fentanyl every9~15days if their VAS scores were found to be more than6scores.
     方法:头颈部鳞癌接受全程放疗过程中出现严重口咽部粘膜溃烂伴疼痛患者30例,其直观模拟标度尺评分法(VAS)评分≥6分时,给予芬太尼透皮贴2.5mg(25μg/h)3贴~5贴/9d~15d。
短句来源
     Objective To evaluate the efficacy and safety of Transdermal Fentanyl in the treatment of opioid naIve and morphine pretreated cancer patients.
     目的评价未接受过阿片类药物与使用过吗啡治疗的肿瘤患者使用芬太尼透皮贴剂治疗癌痛的疗效和安全性。
短句来源
更多       
  “transdermal fentanyl”译为未确定词的双语例句
     The median dosage of transdermal fentanyl is 7.5mg. The range of dosage was from 2.5mg to 7.5mg in 92.9% patients.
     芬太尼的中位剂量7.5mg,其中92.9%患者在2.5~10mg之内。
短句来源
     The minimum dosage of Transdermal Fentanyl was 25 μg/h and the maximum 375 μg/h,average time of treatment was(90.5) d.
     治疗剂量最小为25μg/h,最大为375μg/h,平均治疗时间为90.5 d。
短句来源
     Results With the use of transdermal fentanyl,9 cases (31.03%)had complete remission of pain, 16 cases(55.17%)had partial remission of pain, and 4 cases( 13.8%)had no remission. The total gratification rate of analgesia was 86.2%,with a scale of VAS 1.93±1.77 in the treatment group and 6.43±2.90 in the control group.
     结果治疗组疼痛完全缓解9例(31.03%),疼痛部分缓解16例(55.17%),疼痛未缓解4例(13.8%),镇痛满意率86.2%,VAS评分(1.93±1.77)分;
短句来源
     No severe side effects were noted. Conclusion The Ⅳ morphine / transdermal fentanyl conversion ratio is 31 (mg·day-1) : 1(mg·day-1) .
     结论 静脉吗啡日消耗量(mg/d)与芬太尼贴剂(mg/d)的转换比例是31:1。
短句来源
     Results: Among all cases, 176(72.73%) received opioid therapy. In these patients, 134 (76.14%) took MS-Contin and 28 (15.91%) accepted transdermal fentanyl. Furthermore, weak opioids were taken by 14 (7.95%) patients.
     结果:176例(72.73%)用阿片止痛,其中134例(76.14%)用美施康定,28例(15.91%)用多瑞吉,14例(7.95%)用弱阿片,无阿片过量引起的死亡。
短句来源
更多       
查询“transdermal fentanyl”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  transdermal fentanyl
Pain Recurrence on the Third Day after Application of a Transdermal Fentanyl Patch
      
Neurophysiologic disorders developed in three patients after discontinuation of transdermal fentanyl (TDF) at a daily dose of 0.6?mg (2.5?mg per a patch), although direct removal of a 2.5?mg patch is permitted by the manufacturer as the
      
Withdrawal symptom after discontinuation of transdermal fentanyl at a daily dose of 0.6 mg
      
Transdermal fentanyl treatment in opioid-na?ve cancer patients
      
Transdermal fentanyl seems to be a good palliative measure to treat CNH in patients who have advanced neoplasms.
      
更多          


OBJECTIVE:The effect and clinical application of transdermal fentanyl (Durogesic)in treatment of cancer pains is evaluated.METHODS:Studies concerning the pharmacology and clinical uses of transdermal fentanyl were reviewed.RESULTS:Positive results have been obtained for transdermal fentanyl in treatment of cancer pains,its action can be lasted for 72 hours.It is a simple,convenient and noninvasive agent for relief pains especially useful in patients with difficulties in taking food,with severe...

OBJECTIVE:The effect and clinical application of transdermal fentanyl (Durogesic)in treatment of cancer pains is evaluated.METHODS:Studies concerning the pharmacology and clinical uses of transdermal fentanyl were reviewed.RESULTS:Positive results have been obtained for transdermal fentanyl in treatment of cancer pains,its action can be lasted for 72 hours.It is a simple,convenient and noninvasive agent for relief pains especially useful in patients with difficulties in taking food,with severe nausea,vomiting or constipation.CONCLUSION:Transdermal fentanyl is a new and effective method for controlling cancer pains.

目的:评价芬太尼缓释透皮贴剂(TDF,多瑞吉,Durogesic)在癌痛治疗中的作用及临床应用。方法:综述TDF药理学及临床应用的文献。结果:TDF治疗癌症疼痛疗效肯定,作用持续72h。其用药无创伤性,简单方便,特别适于进食困难、严重恶心呕吐或便秘的癌症疼痛患者。结论:TDF是有效控制癌症疼痛的治疗新方法。

OBJECTIVE :To evaluate the efficacy and safety of transdermal fentanyl in treatment of severe cancer pain. METHODS :32 patients were recruited into a randomized,open, twoperiod,crossover study to compare transdermal fentanyl with a sustainedrelease oral morphine and another 38 patients were recruited into an open study.The fentanyl patches were replaced every 72 h and sustainedrelease morphine was administrated every 12 h. RESULTS]:Pain relief was good throughout the study with side effects,such...

OBJECTIVE :To evaluate the efficacy and safety of transdermal fentanyl in treatment of severe cancer pain. METHODS :32 patients were recruited into a randomized,open, twoperiod,crossover study to compare transdermal fentanyl with a sustainedrelease oral morphine and another 38 patients were recruited into an open study.The fentanyl patches were replaced every 72 h and sustainedrelease morphine was administrated every 12 h. RESULTS]:Pain relief was good throughout the study with side effects,such as dizziness and nausea,similar to that of sustainedrelease morphine.

目的:观察芬太尼透皮贴剂(多瑞吉)对晚期癌症伴重度疼痛患者的镇痛效果及其不良反应。方法:采用多中心随机自身对照及开放试验设计,对照药选用缓释吗啡片,二种药物均采用滴定法给药原则,至24h无疼痛或基本不痛为止。多瑞吉q72h一贴,缓释吗啡q12h一次。评价指标为疼痛强度、疼痛缓解率、生活质量等。结果:多瑞吉可使患者的疼痛强度降低到3.0以下,中度疼痛缓解率达到100%,生活质量明显改善。与对照组相比,不良反应略低,但无显著性差异。结论:多瑞吉可有效地控制上述疼痛,不良反应较低,患者接受程度好。

To compare the efficiency and safety of transdermal fentanyl and sustained release morphine in the treatment of cancer pain,35 late stage cancer patients requiring opioid to relieve their cancer pain were enrolled into the self controlled study All the patients finished both transdermal fentanyl and sustained release morphine treatments The result showed that the remission rate,spectra and incidence of adverse reactions of transdermal...

To compare the efficiency and safety of transdermal fentanyl and sustained release morphine in the treatment of cancer pain,35 late stage cancer patients requiring opioid to relieve their cancer pain were enrolled into the self controlled study All the patients finished both transdermal fentanyl and sustained release morphine treatments The result showed that the remission rate,spectra and incidence of adverse reactions of transdermal fentanyl were similar to those of sustained release morphine However,a slightly significant(P<0 05)higher CR was observed for transdermal fentanyl In addition,the incidence of constipation was lower(P<0 05)in transdermal fentanyl treatment This suggested that as a WHO third stage cancer pain relieving modality,transdermal fentanyl display a comparable or slightly superior efficiency and safety profile for the management of cancer pain,and was more suitable for adult and children cancer pain cases who were unable to take opioids per oral

对 35例需强阿片类药镇痛的晚期癌痛患者进行芬太尼贴剂和口服控释吗啡的自身对照治疗 ,以比较两药控制癌痛的疗效及安全性。结果发现 ,两药治疗癌痛的总体缓解率、副反应谱及发生率均相近 ,但芬太尼贴剂控制癌痛的完全缓解率略高于口服控释吗啡 (P <0 .0 5 ) ,便秘的发生率略低 (P <0 .0 5 )。认为芬太尼透皮贴剂作为 WHO第三阶梯镇痛药具有与口服吗啡相近的疗效和安全性 ,尤其适用于不能口服镇痛药的癌痛患者。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关transdermal fentanyl的内容
在知识搜索中查有关transdermal fentanyl的内容
在数字搜索中查有关transdermal fentanyl的内容
在概念知识元中查有关transdermal fentanyl的内容
在学术趋势中查有关transdermal fentanyl的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社